iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Sets New 12-Month High – Time to Buy?

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)’s share price reached a new 52-week high during trading on Wednesday . The company traded as high as $95.71 and last traded at $95.35, with a volume of 368115 shares traded. The stock had previously closed at $94.12.

iShares U.S. Pharmaceuticals ETF Price Performance

The stock’s fifty day simple moving average is $89.90 and its two-hundred day simple moving average is $87.93. The company has a market capitalization of $1.03 billion, a price-to-earnings ratio of 17.75 and a beta of 0.50.

Hedge Funds Weigh In On iShares U.S. Pharmaceuticals ETF

Large investors have recently bought and sold shares of the business. EFG International AG bought a new stake in shares of iShares U.S. Pharmaceuticals ETF in the 4th quarter worth approximately $38,000. Assetmark Inc. grew its stake in iShares U.S. Pharmaceuticals ETF by 203.9% during the 4th quarter. Assetmark Inc. now owns 465 shares of the company’s stock worth $39,000 after buying an additional 312 shares during the last quarter. O Shaughnessy Asset Management LLC increased its position in iShares U.S. Pharmaceuticals ETF by 35.0% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 463 shares of the company’s stock worth $39,000 after buying an additional 120 shares during the period. Blueline Advisors LLC acquired a new stake in iShares U.S. Pharmaceuticals ETF in the fourth quarter worth $41,000. Finally, Ameriflex Group Inc. lifted its stake in iShares U.S. Pharmaceuticals ETF by 100.0% in the third quarter. Ameriflex Group Inc. now owns 582 shares of the company’s stock valued at $42,000 after buying an additional 291 shares during the last quarter.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.